• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体肿瘤。诊断与管理的当前概念。

Pituitary tumors. Current concepts in diagnosis and management.

作者信息

Aron D C, Tyrrell J B, Wilson C B

机构信息

Division of Clinical and Molecular Endocrinology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

出版信息

West J Med. 1995 Apr;162(4):340-52.

PMID:7747500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1022773/
Abstract

Diagnostic advances have resulted in earlier and more frequent recognition of pituitary tumors. Pituitary tumors cause problems owing to the hormones they secrete or the effects of an expanding sellar mass--hypopituitarism, visual field abnormalities, and neurologic deficits. Prolactin-secreting tumors (prolactinomas), which cause amenorrhea, galactorrhea, and hypogonadism, constitute the most common type of primary pituitary tumors, followed by growth hormone-secreting tumors, which cause acromegaly, and corticotropin-secreting tumors, which cause Cushing's syndrome. Hypersecretion of thyroid-stimulating hormone, the gonadotrophins, or alpha-subunits is unusual. Nonfunctional tumors currently represent only 10% of all clinically diagnosed pituitary adenomas, and some of these are alpha-subunit-secreting adenomas. Insights into the pathogenesis and biologic behavior of these usually benign tumors have been gained from genetic studies. We review some of the recent advances and salient features of the diagnosis and management of pituitary tumors, including biochemical and radiologic diagnosis, transsphenoidal surgery, radiation therapy, and medical therapy. Each type of lesion requires a comprehensive but individualized treatment approach, and regardless of the mode of therapy, careful follow-up is essential.

摘要

诊断技术的进步使得垂体肿瘤能够被更早且更频繁地识别出来。垂体肿瘤因其分泌的激素或蝶鞍区肿块增大产生的影响而引发问题,如垂体功能减退、视野异常和神经功能缺损。分泌催乳素的肿瘤(催乳素瘤)会导致闭经、溢乳和性腺功能减退,是最常见的原发性垂体肿瘤类型,其次是分泌生长激素的肿瘤,可导致肢端肥大症,以及分泌促肾上腺皮质激素的肿瘤,会引发库欣综合征。促甲状腺激素、促性腺激素或α亚基分泌过多的情况较为罕见。目前,无功能肿瘤仅占所有临床诊断垂体腺瘤的10%,其中一些是分泌α亚基的腺瘤。通过遗传学研究,人们对这些通常为良性肿瘤的发病机制和生物学行为有了深入了解。我们回顾垂体肿瘤诊断和治疗的一些最新进展及显著特点,包括生化和放射学诊断、经蝶窦手术、放射治疗和药物治疗。每种类型的病变都需要综合但个体化的治疗方法,并且无论采用何种治疗方式,密切随访都是必不可少的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/7d7de9590d03/westjmed00056-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/eab802821839/westjmed00056-0050-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/3064a8a463b0/westjmed00056-0052-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/7d7de9590d03/westjmed00056-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/eab802821839/westjmed00056-0050-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/3064a8a463b0/westjmed00056-0052-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/772e/1022773/7d7de9590d03/westjmed00056-0058-a.jpg

相似文献

1
Pituitary tumors. Current concepts in diagnosis and management.垂体肿瘤。诊断与管理的当前概念。
West J Med. 1995 Apr;162(4):340-52.
2
Diagnosis and treatment of pituitary adenomas.垂体腺瘤的诊断与治疗
Minerva Endocrinol. 2004 Dec;29(4):241-75.
3
Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.垂体肿瘤及其他鞍内异常肿块的诊断、治疗及预后。对353例患者的回顾性分析。
Medicine (Baltimore). 1999 Jul;78(4):236-69. doi: 10.1097/00005792-199907000-00004.
4
Diagnosis and management of hormone-secreting pituitary adenomas.分泌激素垂体腺瘤的诊断与管理
N Engl J Med. 1991 Mar 21;324(12):822-31. doi: 10.1056/NEJM199103213241207.
5
Diagnosis and Management of Pituitary Adenomas: A Review.垂体腺瘤的诊断与管理:综述
JAMA. 2023 Apr 25;329(16):1386-1398. doi: 10.1001/jama.2023.5444.
6
Diagnosis and Treatment of Pituitary Adenomas: A Review.垂体腺瘤的诊断与治疗:综述
JAMA. 2017 Feb 7;317(5):516-524. doi: 10.1001/jama.2016.19699.
7
Surgical management of pituitary adenomas.垂体腺瘤的外科治疗
Singapore Med J. 2002 Jun;43(6):318-23.
8
Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.老年垂体瘤的诊断与管理:基于个人经验和文献证据的综述
Eur J Endocrinol. 2005 Dec;153(6):723-35. doi: 10.1530/eje.1.02030.
9
Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.垂体腺瘤的两步发展:从高催乳素血症综合征到库欣病。
J Endocrinol Invest. 1997 Apr;20(4):240-4. doi: 10.1007/BF03346911.
10
[Hyperprolactinemia unrelated to prolactinoma].[与泌乳素瘤无关的高泌乳素血症]
Wiad Lek. 2014;67(2 Pt 1):101-11.

引用本文的文献

1
Reproductive Health Assessment of Female Elephants in North American Zoos and Association of Husbandry Practices with Reproductive Dysfunction in African Elephants (Loxodonta africana).北美动物园雌性大象的生殖健康评估以及非洲象(Loxodonta africana)饲养管理实践与生殖功能障碍的关联
PLoS One. 2016 Jul 14;11(7):e0145673. doi: 10.1371/journal.pone.0145673. eCollection 2016.
2
Endoscopic Trans-Nasal Trans-Sphenoidal (TNTS) Approach For Pituitary Adenomas: Our Experience.经鼻内镜经蝶窦(TNTS)入路治疗垂体腺瘤:我们的经验。
Indian J Otolaryngol Head Neck Surg. 2013 Aug;65(Suppl 2):308-13. doi: 10.1007/s12070-011-0457-6. Epub 2012 Jan 5.
3

本文引用的文献

1
Thyrotropin-producing pituitary adenomas.促甲状腺素分泌型垂体腺瘤
J Neurosurg. 1993 Oct;79(4):521-7. doi: 10.3171/jns.1993.79.4.0521.
2
Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients.奥曲肽治疗促甲状腺激素分泌型垂体腺瘤。52例患者的随访
Ann Intern Med. 1993 Aug 1;119(3):236-40. doi: 10.7326/0003-4819-119-3-199308010-00010.
3
Tumors of the sellar region mimicking pituitary adenomas.鞍区肿瘤酷似垂体腺瘤。
Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.
促红细胞生成素通过促进血管生成促进垂体腺瘤的生长。
Int J Oncol. 2012 Apr;40(4):1230-7. doi: 10.3892/ijo.2011.1261. Epub 2011 Nov 11.
4
Pituitary Adenomas.垂体腺瘤
Curr Treat Options Neurol. 2002 Jul;4(4):261-269. doi: 10.1007/s11940-002-0026-0.
5
Advances in diagnosing and managing pituitary adenomas.垂体腺瘤诊断与管理的进展
West J Med. 1995 Apr;162(4):371-3.
Exp Clin Endocrinol. 1993;101(5):283-9. doi: 10.1055/s-0029-1211245.
4
Epidemiology of acromegaly in the Newcastle region.纽卡斯尔地区肢端肥大症的流行病学。
Clin Endocrinol (Oxf). 1980 Jan;12(1):71-9. doi: 10.1111/j.1365-2265.1980.tb03135.x.
5
Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas.未治疗的泌乳素分泌型垂体腺瘤患者的纵向评估。
Am J Obstet Gynecol. 1981 Apr 1;139(7):835-44. doi: 10.1016/0002-9378(81)90553-6.
6
Epidemiology of pituitary adenomas.垂体腺瘤的流行病学
Epidemiol Rev. 1981;3:163-83. doi: 10.1093/oxfordjournals.epirev.a036232.
7
Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.患有泌乳素瘤的女性在选择性经蝶窦腺瘤切除术后高泌乳素血症的复发情况。
N Engl J Med. 1983 Aug 4;309(5):280-3. doi: 10.1056/NEJM198308043090505.
8
The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.促甲状腺激素释放激素试验在分泌催乳素的垂体瘤和鞍上非垂体瘤患者中的价值。
Fertil Steril. 1981 Feb;35(2):155-61. doi: 10.1016/s0015-0282(16)45315-x.
9
Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients.经蝶窦显微手术治疗泌乳素型垂体腺瘤。100例患者的结果。
Mayo Clin Proc. 1983 Feb;58(2):108-21.
10
Oral contraceptive agents do not affect serum prolactin in normal women.口服避孕药对正常女性的血清催乳素水平无影响。
Clin Endocrinol (Oxf). 1984 Apr;20(4):427-34. doi: 10.1111/j.1365-2265.1984.tb03438.x.